About
A careful publication on peptide therapy, written for women.
Anthivera compares and explains peptide therapy options for women — research-grounded, vendor-neutral, and built around what actually matters.
Why we made this
Peptide therapy is one of the most-searched and least-explained corners of women's health right now. The regulatory landscape shifted in 2026, the evidence varies sharply from one peptide to the next, and the loudest voices online are usually the ones with something to sell. Anthivera exists to be the calm, accurate explainer — for women researching their options, by women who care about getting it right.
Who we write for
If you're here, you belong here.
We write for women — and we mean that inclusively. Trans women, cis women, and anyone navigating peptide therapy from a body shaped by feminine hormones, ovulatory cycles, perimenopause, or the experience of moving through the world as a woman.
When individual editors and contributors publish under their own bylines, you'll see their pronouns alongside their name. If you'd ever like us to update language on a specific page, tell us — we'll listen.
How we work
Four rules. Four habits. We hold ourselves to all eight.
Everything we publish runs through this. If a page on this site ever falls short, please flag it — we'd rather hear it from you than not at all.
Four rules · what we promise
Inform, don't prescribe
We're an editorial publication, not a clinic. We summarize evidence and compare options — decisions about your body belong to you and a licensed clinician.
Name the evidence
We say whether something is FDA-approved, compounded, research-only, or a dietary supplement — and how strong the data is. "Promising" is not the same as "proven," and we don't pretend it is.
Disclose how we make money
Some links on this site are affiliate links. We tell you when, and we never let an affiliate relationship change a rating.
Stay current
Peptide regulation has shifted in 2026 and is still moving. Each page carries an updated date. We re-check what we publish and revise when the picture changes.
Four habits · how we actually do it
Sources we trust
FDA pages and Federal Register entries; peer-reviewed studies on PubMed/PMC; the Pharmacy Compounding Advisory Committee record; statements from established medical societies. We link to the primary source whenever possible.
Sources we don't
Influencer testimonials, unsourced wellness claims, product-page marketing copy, and "research chemical" vendor sites. They may surface a topic we cover, but they don't anchor a claim.
Evaluating providers
A small set of editorial criteria — credentials, pharmacy sourcing, monitoring, and pricing transparency among them — applied the same way to every provider. Editorial ratings come from these alone; never from commercial relationships.
Evaluating peptides
We describe what a peptide is, the strength of human evidence (separately from preclinical data), the current regulatory status with a date, and what it has been studied for in women specifically.
How we make money
Reader-supported. Partner-supported. Editorially independent.
Some outbound links to providers are affiliate links — when you click through and sign up, we may earn a commission at no extra cost to you. We label sponsored placement clearly when it exists. Affiliate relationships never raise a rating; if you ever suspect otherwise, email us. Our full affiliate disclosure spells out the details.
From our desk to yours
Tips, corrections, sources, pushback — whatever you have, send it our way. We read everything.
— The Anthivera editors